Laboratory Medicine Program

Acute Leukemia: NPM1 qPCR

Clinical Decription:
Mutations in the NPM1 gene define a specific acute myeloid leukemia (AML) entity associated with an overall good outcome. Quantitative reverse transcriptase PCR is performed to detect the NPM1 variants and monitor AML treatment response known as minimal residual disease monitoring.

Method: PCR

Component Tests Used: n/a

Reference Ranges Used:
Reference ranges for this test are not available online. However, they are included in all test results. For more information, please call us.

Specimen Type: Peripheral Blood/Bone Marrow
Volume: n/a

Shipping: room temperature or 4C

Special Instructions: See requisitions for the full list of available testing and special instructions.

Testing Schedule(s): Please call

Turnaround Time: None

For more information, call 416.340.5227 or 1.866.865.5227